BVF INC/IL Diversified Active

Location: San Francisco, CA

CIK: 0001056807 · Show all filings

Period: Q4 2020 (← Previous) (Next →)

Filing Date: Feb 12, 2021

Total Value: $2.542B (100.0% shares, 0.0% debt)

Holdings (68)

OLMA OLEMA PHARMACEUTICALS INC 12.6%
Value $320M Shares 6,661,503 Est. Cost Unrealized
XOMA XOMA CORP DEL 7.3%
Value $185M Shares 4,182,243 Est. Cost Unrealized
KYMR KYMERA THERAPEUTICS INC 6.4%
Value $163M Shares 2,630,658 Est. Cost Unrealized
RLAY RELAY THERAPEUTICS INC 5.0%
Value $128M Shares 3,073,147 Est. Cost Unrealized
RVMD REVOLUTION MEDICINES INC 4.3%
Value $110M Shares 2,768,049 Est. Cost Unrealized
REPARE THERAPEUTICS INC 4.0%
Value $102M Shares 2,972,191 Est. Cost Unrealized
MERUS N V 4.0%
Value $102M Shares 5,805,571 Est. Cost Unrealized
CYTK CYTOKINETICS INC 4.0%
Value $101M Shares 4,878,035 Est. Cost Unrealized
PTGX PROTAGONIST THERAPEUTICS INC 3.4%
Value $86.16M Shares 4,273,588 Est. Cost Unrealized
IONS IONIS PHARMACEUTICALS INC 3.0%
Value $77.15M Shares 1,364,461 Est. Cost Unrealized
RCUS ARCUS BIOSCIENCES INC 2.8%
Value $71.45M Shares 2,752,222 Est. Cost Unrealized
XNCR XENCOR INC 2.2%
Value $55.18M Shares 1,264,754 Est. Cost Unrealized
XENE XENON PHARMACEUTICALS INC 2.1%
Value $53.82M Shares 3,499,346 Est. Cost Unrealized
AMARIN CORP PLC 2.1%
Value $52.62M Shares 10,761,593 Est. Cost Unrealized
ACIU AC IMMUNE SA 2.0%
Value $50.75M Shares 9,816,658 Est. Cost Unrealized
ALXO ALX ONCOLOGY HLDGS INC 1.8%
Value $46.62M Shares 540,837 Est. Cost Unrealized
FDMT 4D MOLECULAR THERAPEUTICS IN 1.8%
Value $45.85M Shares 1,106,070 Est. Cost Unrealized
IDYA IDEAYA BIOSCIENCES INC 1.8%
Value $45.17M Shares 3,226,769 Est. Cost Unrealized
ESSA PHARMA INC 1.7%
Value $44.2M Shares 3,705,289 Est. Cost Unrealized
SPRO SPERO THERAPEUTICS INC 1.7%
Value $43.5M Shares 2,243,278 Est. Cost Unrealized
KURA KURA ONCOLOGY INC 1.6%
Value $40.69M Shares 1,245,912 Est. Cost Unrealized
SUTRO BIOPHARMA INC 1.6%
Value $40.25M Shares 1,854,162 Est. Cost Unrealized
LXRX LEXICON PHARMACEUTICALS INC 1.5%
Value $37.49M Shares 10,963,000 Est. Cost Unrealized
INFIQ INFINITY PHARMACEUTICALS INC 1.5%
Value $36.95M Shares 17,426,968 Est. Cost Unrealized
CTMX CYTOMX THERAPEUTICS INC 1.4%
Value $36.53M Shares 5,576,471 Est. Cost Unrealized
GLYCOMIMETICS INC 1.4%
Value $35.89M Shares 9,544,262 Est. Cost Unrealized
FORTE BIOSCIENCES INC 1.0%
Value $26.17M Shares 718,788 Est. Cost Unrealized
CALLIDITAS THERAPEUTICS AB 1.0%
Value $25.49M Shares 750,000 Est. Cost Unrealized
VERASTEM INC 0.9%
Value $23.82M Shares 11,180,994 Est. Cost Unrealized
IMVT IMMUNOVANT INC 0.9%
Value $23.76M Shares 514,370 Est. Cost Unrealized
CTI BIOPHARMA CORP 0.9%
Value $22.31M Shares 6,929,690 Est. Cost Unrealized
CALITHERA BIOSCIENCES INC 0.8%
Value $21.41M Shares 4,361,238 Est. Cost Unrealized
MOLECULAR TEMPLATES INC 0.8%
Value $20.18M Shares 2,149,057 Est. Cost Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 0.8%
Value $19.54M Shares 878,524 Est. Cost Unrealized
ARGX ARGENX SE 0.7%
Value $18.38M Shares 62,491 Est. Cost Unrealized
FIVE PRIME THERAPEUTICS INC 0.7%
Value $17.67M Shares 1,038,678 Est. Cost Unrealized
COGT COGENT BIOSCIENCES INC 0.7%
Value $17.21M Shares 1,532,282 Est. Cost Unrealized
PIERIS PHARMACEUTICALS INC 0.5%
Value $13.74M Shares 5,494,582 Est. Cost Unrealized
THERAPEUTICS ACQUISITION COR 0.5%
Value $13.32M Shares 954,996 Est. Cost Unrealized
NOVUS THERAPEUTICS INC 0.5%
Value $11.75M Shares 763,279 Est. Cost Unrealized
GAMIDA CELL LTD 0.4%
Value $11.27M Shares 1,343,667 Est. Cost Unrealized
MEI PHARMA INC 0.4%
Value $10.69M Shares 4,049,162 Est. Cost Unrealized
GRITSTONE ONCOLOGY INC 0.4%
Value $10.62M Shares 2,695,418 Est. Cost Unrealized
OVID OVID THERAPEUTICS INC 0.4%
Value $10.45M Shares 4,522,051 Est. Cost Unrealized
SELECTA BIOSCIENCES INC 0.4%
Value $10.01M Shares 3,304,963 Est. Cost Unrealized
GNCAQ GENOCEA BIOSCIENCES INC 0.4%
Value $9.71M Shares 4,012,404 Est. Cost Unrealized
BCTG ACQUISITION CORP 0.4%
Value $9.152M Shares 800,000 Est. Cost Unrealized
CONTRAFECT CORP 0.3%
Value $8.08M Shares 1,600,000 Est. Cost Unrealized
CIDARA THERAPEUTICS INC 0.3%
Value $7.479M Shares 3,739,704 Est. Cost Unrealized
CRVS CORVUS PHARMACEUTICALS INC 0.3%
Value $6.92M Shares 1,943,712 Est. Cost Unrealized
ERYTECH PHARMA 0.2%
Value $6.119M Shares 625,000 Est. Cost Unrealized
GALMED PHARMACEUTICALS LTD 0.2%
Value $5.597M Shares 1,799,694 Est. Cost Unrealized
EUCRATES BIOMEDICAL ACQU COR 0.2%
Value $5.33M Shares 500,000 Est. Cost Unrealized
FRAZIER LIFESCIENCES ACQU CO 0.2%
Value $5.205M Shares 500,000 Est. Cost Unrealized
CURIS INC 0.2%
Value $5.135M Shares 626,945 Est. Cost Unrealized
X4 PHARMACEUTICALS INC 0.2%
Value $5.098M Shares 792,892 Est. Cost Unrealized
5 01 ACQUISITION CORP 0.2%
Value $5.085M Shares 500,000 Est. Cost Unrealized
PHAT PHATHOM PHARMACEUTICALS INC 0.2%
Value $5.009M Shares 150,787 Est. Cost Unrealized
REGULUS THERAPEUTICS INC 0.2%
Value $4.558M Shares 3,376,207 Est. Cost Unrealized
FORWARD PHARMA A/S 0.2%
Value $4.557M Shares 647,299 Est. Cost Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $3.437M Shares 1,727,308 Est. Cost Unrealized
JIYA ACQUISITION CORP 0.1%
Value $3.09M Shares 300,000 Est. Cost Unrealized
RZLT REZOLUTE INC 0.1%
Value $2.357M Shares 190,814 Est. Cost Unrealized
LIFESCI ACQUISITION II CORP 0.0%
Value $1.062M Shares 100,000 Est. Cost Unrealized
F-STAR THERAPEUTICS INC 0.0%
Value $255K Shares 25,844 Est. Cost Unrealized
MIRAGEN THERAPEUTICS INC 0.0%
Value $160K Shares 9,747 Est. Cost Unrealized
PANACEA ACQUISITION CORP 0.0%
Value $126K Shares 9,837 Est. Cost Unrealized
SPRINGWORKS THERAPEUTICS INC 0.0%
Value $4,000 Shares 50 Est. Cost Unrealized